Form 4: CPS Technologies CFO Awarded Stock Options
SEC Form 4 Filing
Charles Kellogg Griffith Jr., CFO of CPS Technologies, received stock options exercisable at $2.34 per share on February 28, 2024.
Summary
- Charles Kellogg Griffith Jr., the CFO of CPS Technologies, was granted stock options on February 28, 2024.
- The options are exercisable at a price of $2.34 per share.
- A total of 15,000 options were granted, split into tranches exercisable annually from February 28, 2025, to February 28, 2029, all expiring on February 28, 2034.
- Following the transaction, Griffith directly holds 69,000, 72,000, 75,000, 78,000 and 81,000 options in respective tranches.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine grant of stock options, which is generally viewed as a positive incentive for management.
Positives
- The granting of stock options to the CFO aligns his interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the CFO.
Industry Context
Stock option grants are a common form of executive compensation in publicly traded companies, used to incentivize performance and align management's interests with those of shareholders.
Comparison to Industry Standards
- Executive compensation packages, including stock options, vary significantly across industries and company sizes.
- Comparing the size and terms of these options to those granted to CFOs at similarly sized technology companies would provide a better benchmark.
- Factors such as company performance, industry growth, and individual contributions typically influence the structure of such grants.
Stakeholder Impact
- The stock option grant could potentially increase shareholder value if the CFO's performance leads to company growth.
- Employees may view the grant as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 02/28/2024 | Date of transaction: Grant of stock options. |
| 02/28/2025 | First tranche of options becomes exercisable (3,000 shares). |
| 02/28/2026 | Second tranche of options becomes exercisable (3,000 shares). |
| 02/28/2027 | Third tranche of options becomes exercisable (3,000 shares). |
| 02/28/2028 | Fourth tranche of options becomes exercisable (3,000 shares). |
| 02/28/2029 | Fifth tranche of options becomes exercisable (3,000 shares). |
| 02/28/2034 | Expiration date for all tranches of options. |
| 02/29/2024 | Date of signature on the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.